BofA/Merrill's Rating Change Only Had Short-term Impact, Merck Down 0.9% (MRK)
October 21, 2016 at 01:04 AM EDT
BofA/Merrill upgraded Merck (NYSE:MRK) from Neutral to Buy a week ago. The stock closed at $61.92, which is 0.9% lower than the price one week ago ($62.51).Potential upside of...
